Performance Improvement 1995. Footnotes


Chapter 1 Footnotes

  1. Two PHS Agencies, FDA and IHS, use program funds instead of the 1 percent set-aside to conduct their evaluations. FDA programs are principally authorized by legislation other than the PHS Act, specifically the authority of the Federal Food, Drug, and Cosmetic Act, and funds are appropriated under the Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act. IHS programs are authorized under the Indian Health Care Improvement Act and the Indian Self-Determination Act, and funds are appropriated under the Department of the Interior and Related Agencies Appropriations Act.
  2. In addition to using the set-aside authority for the PHS Agencies and OASH, Congress has used it over the past decade to support special program activities of the National Center for Health Statistics and the Agency for Health Care Policy and Research. Furthermore, the Office of the Secretary has used the authority to support public health-related surveys and high-priority evaluation activities.


Chapter 2 Footnotes

  1. The National Institute of Allergy and Infectious Diseases (NIAID), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute of Environmental Health Sciences (NIEHS).
  2. Oral poliovirus vaccine; hepatitis B vaccine; and measles, mumps, and rubella.
  3. Diphtheria, tetanus, pertussis vaccine.
  4. ATSDR, an agency of the Public Health Service, is closely aligned with but not part of CDC. For the purposes of this study, ATSDR was defined as a CDC activity.


Chapter 3 Footnotes

  1. American Indians and Alaska Natives will hereinafter be referred to as American Indians.

View full report


"PerformanceImprovement1995.pdf" (pdf, 941.92Kb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®